Test Code ATTG Antithrombin Antigen, Plasma
Performing Laboratory
Mayo Clinic Laboratories in RochesterReporting Name
Antithrombin Antigen, PUseful For
Assessing abnormal results of the antithrombin activity assay (ATTF / Antithrombin Activity, Plasma), the recommended primary (screening) antithrombin assay
Diagnosing antithrombin deficiency, acquired or congenital, in conjunction with measurement of antithrombin activity
An adjunct in the diagnosis and management of carbohydrate-deficient glycoprotein syndromes
Special Instructions
Ordering Guidance
For monitoring treatment of antithrombin deficiency disorders, including infusion of antithrombin therapeutic concentrate, order ATTF / Antithrombin Activity, Plasma.
Necessary Information
If patient is being treated with heparin, this should be noted as heparin treatment may lower plasma antithrombin.
Specimen Required
Specimen Type: Platelet-poor plasma
Patient Preparation: Fasting preferred
Collection Container/Tube: Light-blue top (3.2% sodium citrate)
Submission Container/Tube: Polypropylene vial
Specimen Volume: 1 mL
Collection Instructions:
1. For complete instructions, see Coagulation Guidelines for Specimen Handling and Processing.
2. Centrifuge, transfer all plasma into a plastic vial, and centrifuge plasma again.
3. Aliquot plasma into a plastic vial leaving 0.25 mL in the bottom of centrifuged vial.
4. Freeze plasma immediately (no longer than 4 hours after collection) at -20° C or, ideally, at-40° C or below.
Additional Information:
1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results.
2. Each coagulation assay requested should have its own vial.
Specimen Minimum Volume
0.5 mL
Specimen Type
Plasma Na CitSpecimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma Na Cit | Frozen | 14 days |
Day(s) Performed
Monday through Friday
Reference Values
Adults: 80-120%
Normal, full-term newborn infants may have decreased levels (≥35-40%) that reach adult levels by 180 days postnatal.*
Healthy, premature infants (30-36 weeks gestation) may have decreased levels that reach adult levels by 180 days postnatal.*
*See Pediatric Hemostasis References section in Coagulation Guidelines for Specimen Handling and Processing.
Test Classification
This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.Method Name
Latex Immunoassay (LIA)
CPT Code Information
85301
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
ATTI | Antithrombin Antigen, P | 27812-7 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
ATTI | Antithrombin Antigen, P | 27812-7 |
Report Available
Same day/1 to 4 daysForms
If not ordering electronically, complete, print, and send a Coagulation Test Request (T753) with the specimen.